Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Methodological strategies and results of a double-blind, placebo-controlled tr

scientific article published on 01 May 1996

Evaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Methodological strategies and results of a double-blind, placebo-controlled tr is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1161/01.STR.27.5.858
P698PubMed publication ID8623106

P2093author name stringS Jonas
A T Culliford
G Grieco
M d'Hollosy
P433issue5
P407language of work or nameEnglishQ1860
P921main subjectneuropsychologyQ3872
placeboQ269829
P304page(s)858-874
P577publication date1996-05-01
P1433published inStroke JournalQ7624282
P1476titleEvaluating neuroprotective agents for clinical anti-ischemic benefit using neurological and neuropsychological changes after cardiac surgery under cardiopulmonary bypass. Methodological strategies and results of a double-blind, placebo-controlled trial of GM1 ganglioside
P478volume27